Top compounds associated with response to CD300LG


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA MP470 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.002
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.003
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.095 0.003
mRNA paclitaxel UHNBreast pan-cancer AAC -0.76 0.004
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.006
mRNA XMD8-85 GDSC1000 pan-cancer AAC 0.14 0.006
Download CSV